US · Healthcare · Health Information Services
EPS came in at 0.14 against a street estimate of 0.16 — a miss of 12.5%.
Analysts rate Doximity Inc a buy (8 buy, 11 hold, 0 sell out of 19) with an average price target of $29.94.
CONFIDENT Doximity beat Q1 FY27 with 7% YoY revenue growth ($157M) and 48% EBITDA margins. AI search launched with strong early traction; Ask won independent NOHARM clinical accuracy study. Company raised full-year guidance $6M on stable pharma environment and AI commercialization momentum. Q1 FY27 Not discussed. Analysts pressed on NOHARM competitive edge (enterprise shift to safety/accuracy), AI search monetization timing (deferred to Q3, deliberate conservative ramp), and pharma budget unlock (new AI+analytics spend vs. cannibalization). Management framed all as long-term TAM expansion with margin-accretive unit economics. 2026-08-06…
Full summary in the app.
| Fund | Stake |
|---|---|
| BlackRock Inc | 8.00% |
| Vanguard Portfolio Management, LLC | 3.59% |
| D. E. Shaw & Co LP | 3.32% |
| Vanguard Capital Management, LLC | 3.23% |
| ClearBridge Advisors, LLC | 2.79% |
| Two Sigma Investments LLC | 2.61% |
| Carmignac Gestion | 2.42% |
| State Street Corp | 2.27% |
| Document | Date |
|---|---|
| Shareholder vote results · Q2 FY2027 DOXIMITY, INC. (DOCS) - FORM 8-K SUMMARY HEADLINE NUMBERS • Annual Meeting held August 27, 2026 with 614,551,986 votes represented (96.34% of total | 2026-09-02 |
| Quarterly report · Q1 FY2027 DOXIMITY, INC. – Q1 FY2027 (QUARTER ENDED JUNE 30, 2026) SUMMARY HEADLINE NUMBERS • Revenue: $156.6 million (Q1 2026) vs. $145.9 million (Q1 2025) = | 2026-08-06 |
| Results announced · Q2 FY2027 DOXIMITY, INC. – FISCAL 2027 Q1 RESULTS SUMMARY HEADLINE NUMBERS • Revenue: $156.6 million, up 7% year-over-year (vs. $145.9 million in Q1 FY2026) • | 2026-08-06 |
| Proxy statement · Q2 FY2027 DOXIMITY, INC. – PROXY STATEMENT SUMMARY HEADLINE NUMBERS • Annual Meeting scheduled: August 27, 2026 at 9:00 a.m. Pacific Time (virtual audio-only | 2026-07-15 |
| Annual report FY2026 DOXIMITY, INC. – FORM 10-K SUMMARY (Fiscal Year Ended March 31, 2026) HEADLINE NUMBERS • Market capitalization: $9.86 billion (as of September 30, 2 | 2026-05-19 |
| Results announced · Q1 FY2027 DOXIMITY, INC. – FISCAL YEAR 2026 FINANCIAL SUMMARY HEADLINE NUMBERS • Fiscal Year 2026 Revenue: $644.9 million, up 13% year-over-year (prior year: | 2026-05-13 |
| Board / officer change · Q1 FY2027 DOXIMITY, INC. - FORM 8-K SUMMARY (April 13, 2026) HEADLINE NUMBERS • No financial metrics provided in this filing • Document is a personnel/leadersh | 2026-04-17 |
| Quarterly report · Q3 FY2026 DOXIMITY, INC. – Q3 2026 FORM 10-Q SUMMARY HEADLINE NUMBERS • Revenue (9M ended Dec 31, 2025): $499.5 million vs. $432.1 million prior year (+15.6%) | 2026-02-05 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Doximity Inc — free to start.
Google PlayApp StoreData updated 2026-09-18.